ProteoNic, a provider of premium vector technology and services for efficient production of biologics, and NecstGen, a CDMO and center of excellence for Cell and Gene Therapy, have partnered for the development of improved viral vector manufacturing for gene therapy applications.   Both companies, located on the Leiden Bio Science Park, recognize the need to increase viral titres and optimize production processes. Cost-efficiency and manufacturing yield play a critical role in the feasibility ...